Ovation Science AI Stock Analysis
Ovation Science (0VH) AI Stock Analysis
Ovation Science
(Frankfurt:0VH)
No summary available
Ovation Science (0VH) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 288.31K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -1.1
- Beta (1Y)
- 1.02
- Revenue Growth
- -16.62%
- EPS Growth
- -27.91%
- Country
- Germany
- Employees
- 5
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Ovation Science Business Overview & Revenue Model
Company Description
Ovation Science Inc. specializes in the creation of cannabis and hemp-based products, distributed across Canada, the United States, and Mexico. A cornerstone of its offerings is Invisicare, a patented drug delivery technology employed in topical and...
Ovation Science Peers Comparison
Overall Rating
TSE:LABS53Neutral
TSE:VEXT45Neutral
TSE:OILS43Neutral
TSE:ATLE42Neutral
TSE:BNXT39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 53Neutral | CAD 29.90M | -10.00 | -13.79% | ― | -9.31% | 66.84% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | CAD 50.78M | -1.59 | -31.34% | ― | 9.88% | 0.18% | |
| 43Neutral | CAD 3.40M | -2.19 | -43.92% | ― | -18.30% | -397.37% | |
| 42Neutral | CAD 46.62M | -0.76 | -2099.75% | ― | -96.13% | 88.13% | |
| 39Underperform | CAD 38.11M | -3.38 | 117.02% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:0VH | Ovation Science | 0.01 | -0.01 | -35.29% | |
| TSE:ATLE | Willow Biosciences | 0.10 | -0.08 | -44.12% | |
| TSE:LABS | Medipharm Labs (Otc) | 0.07 | -0.01 | -7.14% | |
| TSE:OILS | Nextleaf Solutions | 0.02 | -0.04 | -63.64% | |
| TSE:VEXT | Vext Science | 0.20 | -0.05 | -18.00% | |
| TSE:BNXT | Bionxt Solutions Inc | 0.28 | -0.44 | -61.11% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
